Press Releases & Events
Press Releases
June 3, 2013
MDxHealth Epigenetic Marker as Companion Diagnostic for Irinotecan based Therapy in Colorectal Cancer
Version Française
Version Française
May 31, 2013
MDxHealth (TM) : Annual and Extraordinary General Shareholders' MeetingVersion Française
Version Française
May 8, 2013
MDxHealth's ConfirmMDx(TM) Combined with PSA and Other Risk Factors, Improves Diagnosis of Prostate CancerVersion Française
Version Française
April 22, 2013
MDxHealth's ConfirmMDx(TM) Test Outperforms PSA in Prostate Cancer Detection Algorithm and Decision for Repeat BiopsyVersion Française
Version Française
April 3, 2013
MDxHealth Announces Publication of the Clinical Utility of Combining Genetics and Epigenetics to Improve Management of Prostate cancerVersion Française
Version Française
April 2, 2013
MDxHealth Receives ISO 9001:2008 Certification for its Commercial U.S. Based CLIA LaboratoryVersion Française
Version Française
March 19, 2013
MDxHealth and Ghent University Aim to Establish Sensitive and Cost-Effective Industry Standard for Genome-wide DNA methylation Profiling ToolsVersion Française
Version Française
February 18, 2013
MDxHealth Announces Results from the ConfirmMDx(TM) for Prostate Cancer Test Studies Presented at the 2013 ASCO Genitourinary Cancers SymposiumVersion Française
Version Française
February 14, 2013
MDxHealth Announces Publication of Health Economic Analysis Demonstrating Cost-Savings of ConfirmMDx for Prostate CancerVersion Française
Version Française
February 13, 2013
MDxHealth Announces Presentations on the ConfirmMDx(TM) for Prostate Cancer Test at the ASCO Genitourinary Cancers Symposium 2013Version Française
Version Française
February 11, 2013
MDxHealth Announces Publication of Positive Data from a Blinded Multicenter Clinical Study Demonstrating the Utility of ConfirmMDxTM for Prostate Cancer to Address False-negative BiopsiesVersion Française
Version Française
Events
February 11-12, 2013
February 14-16, 2013
April 17, 2013
April 23, 2013